It’s been a tumultuous few years for Theranos Inc., the Palo Alto, California-based company that rose to fame in 2004 for its allegedly revolutionary blood-testing technology—then crashed a decade later when The Wall Street Journal reported the tests didn’t work.

The once $9 billion company has been mired in legal problems since, which came to a head June 14 when CEO Elizabeth Holmes was indicted, along with the company’s former chief operating officer and president, on wire fraud charges by the AG’s Office in the Northern District of California.